site stats

Dukoral drug monograph

WebThe use of Dukoral should be determined on the basis of official recommendations taking into account the variability of epidemiology and the risk of contracting disease in different … Web16 feb 2024 · Name of the medicine Composition and pharmaceutical form Clinical particulars, including: Therapeutic indications Dose and method of administration Contraindications Special warning and precautions for use Adverse effects Overdose Pharmacological properties, including: Pharmacodynamic properties Clinical trials …

Dukoral - Utilisations, Effets secondaires, Interactions

Web18 giu 2024 · Dukoral è stato somministrato a bambini di età compresa tra 1 e 2 anni nell’ambito di studi sulla sicurezza e l’immunogenicità, ma l’efficacia protettiva non è … WebDUKORAL Oral suspension / Granules Summary of Product Characteristics (SPC) Medicine classification This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows: ATC code Group title Classification J07AE01 Cholera, inactivated, whole cell png of mountain https://roschi.net

ALLEGATO I RIASSUNTO DELLE CARATTERISTICHE DEL PRODOTTO

WebCATMAT suggests that the oral cholera vaccine (killed whole cells plus recombinant B-subunit, WC-rBS, licenced for use in Canada as Dukoral®Footnote i) not be routinely administered to Canadian travellers as a means of preventing travellers' diarrhea (TD); Conditional recommendation, moderate confidence in estimate of effect versus placebo. WebIn Sicherheits- und Immunogenitätsstudien ist Dukoral Kindern zwischen 1 und 2 Jahren verabreicht worden, die Wirksamkeit des Schutzes ist in dieser Altersgruppe jedoch nicht … Web16 mar 2024 · PRODUCT MONOGRAPH. HAVRIX . hepatitis A vaccine, inactivated . Suspension for injection . Active immunizing agent . against infection by hepatitis A virus . ... Adverse drug reaction information from clinical trials is useful for identifying drug-related adverse events and for approximating rates. png of monster

What is a USP Monograph

Category:Dukoral, INN- Oral Cholera vaccine - European Medicines Agency

Tags:Dukoral drug monograph

Dukoral drug monograph

Cholera and enterotoxigenic escherichia coli (ETEC) travellers ...

Web17 set 2024 · Dukoral is a vaccine that is given by mouth to protect people against cholera, a serious disease that causes severe diarrhoea. It is used in people aged from 2 years … WebThe drug DUKORAL contains a combination of these active pharmaceutical ingredients (APIs): 1 VIBRIO CHOLERAE INABA 48 CLASSICAL BIOTYPE, HEAT INACTIVATED …

Dukoral drug monograph

Did you know?

Web28 nov 2024 · Dukoral è stato somministrato a bambini di età compresa tra 1 e 2 anni nell’ambito di studi sulla sicurezza e l’immunogenicità, ma l’efficacia protettiva non è … WebDukoral is a vaccine. Vaccines work by ‘teaching’ the immune system (the body’s natural defences) how to protect itself against a disease. Dukoral contains small amounts of …

WebPRODUCT MONOGRAPH DUKORAL ... 331 Œ DUKORALfi Page 10 of 27 Drug-Food Interactions Food and drink should be avoided 1 hour before and 1 hour after vaccination … WebThe effervescent granules are filled in an amount of 5.6 g in sachets with an inner layer of polyester/LD-polyethylene and an outer layer of aluminium/LD-polyethylene. Each dose of vaccine is supplied as one vial of suspension together with one sachet of effervescent granules. Pack sizes: 1x1 dose, 2x1 dose, 20x1 dose.

WebDukoral è stato somministrato a bambini di età compresa tra 1 e 2 anni nell’ambito di studi sulla sicurezza e l’immunogenicità, ma l’efficacia protettiva non è stata studiata in questo gruppo di età. Quindi l’uso di Dukoral nei bambini al di sotto dei 2 … WebA monograph is a written document that reflects the quality attributes of medicines approved by the U.S. Food and Drug Administration (US FDA). Some of these attributes include: Identity - Tests to identify that a particular substance is the medicine that it claims to be. Strength - Testing methods and acceptable ranges for the potency of a ...

Web25 feb 2024 · Dukoral è un vaccino disponibile in sospensione in un flaconcino. Contiene come principi attivi quattro diversi ceppi (tipi) inattivati (uccisi) del batterio Vibrio cholerae ( V.cholerae) sierotipo O1 e parte di una tossina derivata da uno di questi ceppi. Dukoral viene fornito insieme a granuli in bustina per preparare la sospensione orale.

Web25 feb 2024 · Dukoral si usa per la protezione contro il colera (una malattia molto grave causata dal V. cholerae, che si contrae da cibi o acqua contaminati e provoca una grave … png of old people laughlng and clappingWebSHINGRIX product monograph(PDF - 331 KB) Patient information: SHINGRIX fact sheet(PDF - 113 KB) Important information(PDF - 124 KB) for patients GSK This website is intended for visitors looking for information on GSK Canada. Other market sites can be reached by visiting our location selector. © 2001-2024 GSK plc. All rights reserved. png of oahuWebSide effects with Dukoral are not common. However, the following side effects are seen in between 1 and 10 patients in 1,000: headache, diarrhoea, and abdominal (tummy) pain, cramps, gurgling (gas) or discomfort. For the full list of side effects reported with Dukoral, see the package leaflet. Dukoral should not be used in people who may be ... png of paperWebPRODUCT MONOGRAPH DUKORAL® Oral, Inactivated Cholera and ETEC Diarrhea Vaccine Oral Suspension Active Immunizing Agent for the Prevention of Diarrhea … png of obamaWebDukoral sia usato in modo sicuro ed efficace sono state riportate nel riassunto delle caratteristiche del prodotto e nel foglio illustrativo. Come per tutti i medicinali, i dati … png of orangeWeb15 ago 2024 · Dukoral è un vaccino orale contro il colera che stimola le difese immunitarie nell’intestino. Il vaccino protegge nei confronti del colera adulti e bambini dai 2 anni in su. … png of pantsWebProduct Monograph PrMALARONE® (250 mg Atovaquone + 100 mg Proguanil Hydrochloride) Tablets PrMALARONE®PEDIATRIC (62.5 mg Atovaquone + 25 mg Proguanil Hydrochloride) Tablets Antimalarial Agent GlaxoSmithKline Inc. 7333 Mississauga Road Mississauga, Ontario L5N 6L4 Date of Revision: August 7, 2015 Submission … png of p